glp-1 type 2 diabetes RA education Clinical Focus on GLP-1 Agonists

Risk of bias: all four RCTs were rated low risk by RoB2 (with some concerns for open-label outcome ascertainment in three trials, a domain-specific issue that does not alter the overall RoB2 category from low)

Learn about safety, monioring, and side effects here.

Henry Meds reviewed: program model, medication options, eligibility, pricing, and editorial context

Truveta Research explores patterns of GLP-1 RA switching from 2018 to 2023 and demographic characteristics of patients who switched.

GLP-1 medications like Ozempic and Mounjaro may support fertility by aiding weight loss, reducing inflammation, and improving hormone balance, but theyre not a cure for infertility